Abstract: An antiviral composition includes an antibody or a fragment thereof, which includes a heavy chain CDR1 (VH CDR1) represented by SEQ ID NO: 1, VH CDR2 represented by SEQ ID NO: 2, VH CDR3 represented by SEQ ID NO: 3, a light chain CDR1 (VL CDR1) represented by SEQ ID NO: 4, VL CDR2 represented by SEQ ID NO: 5, and VL CDR3 represented by SEQ ID NO: 6, so as to exhibit excellent antiviral effects to influenza A virus, while achieving effects of preventing, treating or improving diseases derived from influenza A virus.

Abstract: An antiviral composition for coronavirus includes an antibody or a functional fragment thereof, which includes a heavy chain CDR1 (VH CDR1) represented by SEQ ID NO: 1, VH CDR2 represented by SEQ ID NO: 2, VH CDR3 represented by SEQ ID NO: 3, a light chain CDR1 (VL CDR1) represented by SEQ ID NO: 4, VL CDR2 represented by SEQ ID NO: 5, and VL CDR3 represented by SEQ ID NO: 6, so as to exhibit excellent antiviral effects to coronavirus, while achieving effects of preventing, treating or improving diseases derived from coronavirus.

Abstract: Disclosed herein is a lighting apparatus capable of uniformly maintaining power consumed by light emitting units even in the case in which various voltages are applied, and increasing power efficiency while minimizing a heating problem by adjusting a reference voltage applied to a connection structure of the light emitting units and a distribution switch according to magnitude of the applied voltage.

Abstract: Disclosed herein is a lighting apparatus capable of uniformly maintaining power consumed by light emitting units even in the case in which various voltages are applied, and increasing power efficiency while minimizing a heating problem by adjusting a reference voltage applied to a connection structure of the light emitting units and a distribution switch according to magnitude of the applied voltage.

Abstract: Disclosed herein is a lighting apparatus capable of uniformly maintaining power consumed by light emitting units even in the case in which various voltages are applied, and increasing power efficiency while minimizing a heating problem by adjusting a reference voltage applied to a connection structure of the light emitting units and a distribution switch according to magnitude of the applied voltage.

Abstract: Disclosed herein is a lighting apparatus capable of uniformly maintaining power consumed by light emitting units even in the case in which various voltages are applied, and increasing power efficiency while minimizing a heating problem by adjusting a reference voltage applied to a connection structure of the light emitting units and a distribution switch according to magnitude of the applied voltage.

Abstract: Provided is an antiviral agent against animal viruses. The antiviral agent contains a protein or a nucleic acid sequence encoding the protein, as an active ingredient, the protein having binding ability and degrading ability to foreign nucleic acid chains invaded in an animal cell and that has no cytotoxicity to the animal cell itself. Also provided is an antiviral animal cell containing the protein according to the present invention, or the nucleic acid sequence encoding the protein. The antiviral agent and antiviral animal cell exhibit advantageous effects in that they selectively degrade foreign nucleic acid chains invaded in an animal cell and have no cytotoxicity to the animal cell, thus causing no death of the animal cell.

Abstract: Disclosed herein is an antiviral agent against animal viruses. The antiviral agent contains a protein or a nucleic acid sequence encoding the protein, as an active ingredient, the protein having binding ability and degrading ability to foreign nucleic acid chains invaded in an animal cell and that has no cytotoxicity to the animal cell itself. Disclosed herein is further an antiviral animal cell containing the protein according to the present invention, or the nucleic acid sequence encoding the protein. The antiviral agent and antiviral animal cell exhibit advantageous effects in that they selectively degrade foreign nucleic acid chains invaded in an animal cell and have no cytotoxicity to the animal cell, thus causing no death of the animal cell.

Abstract: Disclosed herein is an antiviral agent against animal viruses. The antiviral agent contains a protein or a nucleic acid sequence encoding the protein, as an active ingredient, the protein having binding ability and degrading ability to foreign nucleic acid chains invaded in an animal cell and that has no cytotoxicity to the animal cell itself. Disclosed herein is further an antiviral animal cell containing the protein according to the present invention, or the nucleic acid sequence encoding the protein. The antiviral agent and antiviral animal cell exhibit advantageous effects in that they selectively degrade foreign nucleic acid chains invaded in an animal cell and have no cytotoxicity to the animal cell, thus causing no death of the animal cell.

Abstract: This invention relates to transgenic plants for producing products of interest such as proteins. Since the transgenic plants according to the invention are cultured in large quantities without culturing tissues and their heredity is preserved through several generations, the invention can yield the products of interest such as proteins in bulk. The invention also provides transgenic plants that are available to the analysis of genomic functions and the production of plants expressing genes by regulating the timing of the expression of the gene of interest by use of proper expression vectors.